Evaluation of thromboelastography for prediction of clinical bleeding in thrombocytopenic dogs after total body irradiation and hematopoietic cell transplantation

American Journal of Veterinary Research

Volumn 75, Issue 5, 2014, Pages 425-432

  Bucknoff, Melissa C ^a   Hanel, Rita M ^b   Marks, Steven L ^b   Motsinger Reif, Alison A ^b   Suter, Steven E ^b  

^a TUFTS UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING; BLEEDING TIME; BONE MARROW TRANSPLANTATION; DOG; EPISTAXIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATURIA; HEMOSTASIS; MALE; MELENA; MUCOSAL BLEEDING; NONHUMAN; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDY; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RECTUM HEMORRHAGE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; COHORT STUDIES; DOG DISEASES; DOGS; HEMORRHAGE; HEMOSTASIS; KAOLIN; LYMPHOMA; MALE; PLATELET COUNT; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY; THROMBOCYTOPENIA; WHOLE-BODY IRRADIATION;

EID: 84899130120     PISSN: 00029645     EISSN: 19435681     Source Type: Journal    
DOI: 10.2460/ajvr.75.5.425     Document Type: Article

References (44)

1. Wiinberg B, Jensen AL, Rozanski E, et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 2009; 179: 121-129.
2. Christopherson PW, Spangler EA, Boudreaux MK. Evaluation and clinical application of platelet function testing in small animal practice. Vet Clin North Am Small Anim Pract 2012; 42: 173-188.
3. McMichael MA, Smith SA. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Pathol 2011; 40: 140-153.
4. Kol A, Borjesson DL. Application of thromboelastography and thromboelastometry to veterinary medicine. Vet Clin Pathol 2010; 39: 405-416.
5. Schöchl H, Maegele M, Solomon C, et al. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20: 15.
6. Kashuk JL, Moore EE, Sawyer M, et al. Post-injury coagulopathy management; goal directed resuscitation via POC thromboelastography. Ann Surg 2010; 251: 604-614.
7. Ak K, Isbir C, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009; 24: 404-410.
8. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thromboelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86: 575-578.
9. Wang SC, Shieh JF, Chang KY, et al. Thromboelastographyguided transfusion decreased intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010; 42: 2590-2593.
10. Apelseth TO, Bruserud O, Wentzel-Larsen T, et al. Therapeu-tic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion 2010; 50: 766-775.
11. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34: 389-393.
12. Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005; 15: 9-16.
13. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217: 1500-1504.
14. Donahue SM, Brooks M, Otto CM. Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy. J Vet Emerg Crit Care (San Antonio) 2011; 21: 346-355.
15. Kristensen AT, Wiinber B, Jessen LR, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22: 140-147.
16. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care (San Antonio) 2009; 19: 484-488.
17. Fenty RK, deLaforacade AM, Shaw SP, et al. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography. J Am Vet Med Assoc 2011; 238: 463-467.
18. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008; 22: 357-365.
19. Rozanski EA, Callan MB, Hughes D, et al. Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs. J Am Vet Med Assoc 2002; 220: 477-481.
20. Escobar C, Grindem C, Neel JA, et al. Hematologic changes after total body irradiation and autologous transplantation of hematopoietic peripheral blood progenitor cells in dogs with lymphoma. Vet Pathol 2012; 49: 341-343.
21. Thrall MA. Classification of and diagnostic approach to anemia. In: Thrall MA, Baker DC, Campbell TW, et al, eds. Veterinary hematology and clinical chemistry. Ames, Iowa: Blackwell Publishing, 2006; 83-89.
22. Christian JA. Erythrokinetics and erythrocyte destruction. In: Weiss JD, Wardrop KJ, eds. Schalm's veterinary hematology. 6th ed. Ames, Iowa: Blackwell Publishing, 2010; 136-143.
23. Suter SE. Collection of peripheral blood CD34+ progenitor cells from healthy dogs diagnosed with lymphoproliferative disease using a Baxter-Fenwal CS-3000 Plus blood cell separator. J Vet Intern Med 2011; 25: 1406-1413.
24. Lupu M, Sullivan EW, Westfall TE, et al. Use of multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma. J Am Vet Med Assoc 2006; 228: 728-732.
25. Millis DL, Hawkins E, Jager M, et al. Comparison of coagulation test results for blood samples obtained by means of direct venipuncture and through a jugular vein catheter in clinically normal dogs. J Am Vet Med Assoc 1995; 207: 1311-1314.
26. TEG 5000 user's manual. Braintree, Mass: Haemonetics Corp, 2007.
27. Jergens AE, Turrentine MA, Kraus KH, et al. Buccal mucosal bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease. Am J Vet Res 1987; 48: 1337-1342.
28. Jain NC. Schalm's veterinary hematology. 4th ed. Philadelphia, 1986.
29. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
30. Bateman SW, Mathews KA, Abrams-Ogg AC, et al. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. J Am Vet Med Assoc 1999; 215: 798-804.
31. Bigge LA, Brown DJ, Penninck DG. Correlation between coagulation profile findings and bleeding complications after ultrasound-guided biopsies: 434 cases (1993-1996). J Am Anim Hosp Assoc 2001; 37: 228-233.
32. Vaden SL, Levine JF, Lees GE, et al. Renal biopsy: a retrospective study of methods and complications in 238 dogs and 65 cats. J Vet Intern Med 2005; 19: 794-801.
33. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413-1425.
34. Friedmann AM, Sengul H, Lehmann H, et al. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 2002; 16: 34-45.
35. Estcourt L, Stanworth S, Doree C. Prophylactic platelet transfusion for prevention of bleeding in patients with hematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev [serial online] 2012; 5: CD004269. Available at onlinelibrary. wiley. com/doi/10. 1002/14651858. CD004269. pub3/abstract; jsessionid=583F7D35412CF9F73656 AE3DBDED0D91. f04t02 Accessed Sep 22, 2011.
36. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for usage of platelet transfusions. Br J Haematol 2003; 122: 10-23.
37. Callan MB, Appleman EH, Sachais BS. Canine platelet transfusions. J Vet Emerg Crit Care (San Antonio) 2009; 19: 401-415.
38. Roeloffzen WWH, Kluin-Nelemans HC, Mulder AB, et al. Thrombocytopenia affects plasmatic coagulation as measured by thromboelastography. Blood Coagul Fibrinolysis 2010; 21: 389-397.
39. Larsen OH, Ingerslev J, Sorensen B. Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions. Ann Hematol 2007; 86: 217-221.
40. Bowbrick VA, Mikhailidis DP, Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets 2003; 14: 219-224.
41. O'Marra SK, Shaw SP, deLaforcade AM. Investigating hypercoagulability during treatment for immune-mediated thrombocytopenia: a pilot study. J Vet Emerg Crit Care (San Antonio) 2012; 22: 126-130.
42. Smith SA, McMichael MA, Gilor S, et al. Results of thromboelastometry on canine whole blood correlate with hematocrit, platelet count, and plasma coagulation factors. Am J Vet Res 2012; 73: 789-798.
43. McMichael M, Smith SA, McConachiea EL, et al. In vitro hypocoagulability on whole blood thromboelastometry associated with in vivo expansion of red cell mass in an equine model. Blood Coagul Fibrinolysis 2011; 22: 424-430.
44. Walker JM, Hanel RM, Hansen BD, et al. Comparison of venous sampling methods for thromboelastography in clinically normal dogs. Am J Vet Res 2012; 73: 1864-1870.